These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22075527)

  • 1. Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.
    Rubinstein WS; Acheson LS; O'Neill SM; Ruffin MT; Wang C; Beaumont JL; Rothrock N;
    Genet Med; 2011 Nov; 13(11):956-65. PubMed ID: 22075527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial.
    Acheson LS; Wang C; Zyzanski SJ; Lynn A; Ruffin MT; Gramling R; Rubinstein WS; O'Neill SM; Nease DE;
    Genet Med; 2010 Apr; 12(4):212-8. PubMed ID: 20216073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial risk for common diseases in primary care: the Family Healthware Impact Trial.
    O'Neill SM; Rubinstein WS; Wang C; Yoon PW; Acheson LS; Rothrock N; Starzyk EJ; Beaumont JL; Galliher JM; Ruffin MT;
    Am J Prev Med; 2009 Jun; 36(6):506-14. PubMed ID: 19460658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family history assessment: impact on disease risk perceptions.
    Wang C; Sen A; Ruffin MT; Nease DE; Gramling R; Acheson LS; O'Neill SM; Rubinstein WS;
    Am J Prev Med; 2012 Oct; 43(4):392-8. PubMed ID: 22992357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of preventive messages tailored to family history on health behaviors: the Family Healthware Impact Trial.
    Ruffin MT; Nease DE; Sen A; Pace WD; Wang C; Acheson LS; Rubinstein WS; O'Neill S; Gramling R;
    Ann Fam Med; 2011; 9(1):3-11. PubMed ID: 21242555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving primary care identification of familial breast cancer risk using proactive invitation and decision support.
    Qureshi N; Dutton B; Weng S; Sheehan C; Chorley W; Robertson JFR; Kendrick D; Kai J
    Fam Cancer; 2021 Jan; 20(1):13-21. PubMed ID: 32524330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial.
    Wu RR; Orlando LA; Himmel TL; Buchanan AH; Powell KP; Hauser ER; Agbaje AB; Henrich VC; Ginsburg GS
    BMC Fam Pract; 2013 Aug; 14():111. PubMed ID: 23915256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of and Interventions for Women at High Risk for Breast or Ovarian Cancer: A Survey of Primary Care Physicians.
    Samimi G; Heckman-Stoddard BM; Holmberg C; Tennant B; Sheppard BB; Coa KI; Kay SS; Ford LG; Szabo E; Minasian LM
    Cancer Prev Res (Phila); 2021 Feb; 14(2):205-214. PubMed ID: 33023915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing Family Healthware, a family history screening tool to prevent common chronic diseases.
    Yoon PW; Scheuner MT; Jorgensen C; Khoury MJ
    Prev Chronic Dis; 2009 Jan; 6(1):A33. PubMed ID: 19080039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire.
    Hughes KS; Roche C; Campbell CT; Siegel N; Salisbury L; Chekos A; Katz MS; Edell E
    Breast J; 2003; 9(1):19-25. PubMed ID: 12558666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
    Hull LE; Haas JS; Simon SR
    Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of extended family history in assessment of risk for breast and colon cancer.
    Solomon BL; Whitman T; Wood ME
    BMC Fam Pract; 2016 Sep; 17(1):126. PubMed ID: 27580697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing a Population-Based Breast Cancer Risk Assessment Program.
    Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A
    Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risk assessment: Evaluation of screening tools for genetics referral.
    Himes DO; Zaro ML; Williams M; Freeborn D; Eggett DL; Kinney AY
    J Am Assoc Nurse Pract; 2019 Oct; 31(10):562-572. PubMed ID: 31425377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Implementing B-RST
    Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
    Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care.
    Baer HJ; Schneider LI; Colditz GA; Dart H; Andry A; Williams DH; Orav EJ; Haas JS; Getty G; Whittemore E; Bates DW
    J Gen Intern Med; 2013 Jun; 28(6):817-24. PubMed ID: 23371384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk assessment: quality and impact of the family history interview.
    Murff HJ; Byrne D; Syngal S
    Am J Prev Med; 2004 Oct; 27(3):239-45. PubMed ID: 15450637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
    Trials; 2014 Mar; 15():86. PubMed ID: 24649895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.